A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?

Research output: Contribution to journalEditorial

Original languageEnglish (US)
JournalBreast Journal
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Breast Neoplasms
fulvestrant

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Cite this

@article{0846f3fe70114aee9e65d161b143793e,
title = "A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?",
author = "Mahtani, {Reshma L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/tbj.13495",
language = "English (US)",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?

AU - Mahtani, Reshma L.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85073999019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073999019&partnerID=8YFLogxK

U2 - 10.1111/tbj.13495

DO - 10.1111/tbj.13495

M3 - Editorial

C2 - 31538681

AN - SCOPUS:85073999019

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

ER -